Symposia Recordings

In effort to bring valuable information and education to a wider audience, the IPC develops webcasts of the symposia taking place at important congresses throughout the year that can be accessed at any time. 

• How to Select a Systemic Treatment that Makes Sense | Craig Leonardi, MD | United States
  
• Innovations in Topical Treatments for Psoriasis | Charles Lynde, MD, FRCPC, DABD, FCDA | Canada
  
• Innovations in Systemic Treatments for Psoriasis | Andrew Blauvelt, MD, MBA | United States
  

International Psoriasis Council: Special populations of patients with psoriasis

2021 EADV Virtual

• Treating Women with Psoriasis | Mahira Hamdy El Sayed, MSc, MD | Egypt
  
• Pustular Psoriasis, Distinct Disease or Part of Psoriasis Spectrum? | Hervé Bachelez, PhD | France
  
• Challenging Case: A Patient with Psoriasis and Cancer | Lluís Puig, MD, PhD | Spain
  
• Personalized Care in Psoriatic Arthritis | Joseph Merola, MD, MMSc | United States 

Research on SARS-CoV-2 during the COVID-19 pandemic crisis: An IPC tribute to young researchers

2021 ESDR Virtual

• Autoantibodies to Type I IFNs in Patient with Life-Threatening COVID-19 | Paul Bastard, MD | France
  
• B-Cell Responses to SARS-CoV-2 in the Setting of COVID-19 Infection & Vaccination | Zijun Wang, PhD | United States
  
• COVID-19 and Psoriasis: Lessons from Real-Life Registries | Satveer Mahil, PhD | United Kingdom
  
• Interactions between Skin Inflammatory Diseases & COVID: Lessons from Genomic Epidemiology Studies| Matthew Patrick, MEng, PhD | United States

The International Psoriasis Council update on the latest research

2021 IFPA Virtual

• IPC’s Disease Severity Classification: What it Means in the Clinic | Lone Skov, MD, PhD | Denmark
  
• The Future of Teledermatology | Alexander Navarini, MD, PhD | Switzerland
  
• Psoriasis and Diet | Jo Lambert, MD, PhD | Belgium
  
• Q & A and closing comments | All faculty

Challenging cases in psoriasis: A focus on COVID-19, biologics and adverse events

2021 RADLA Virtual

• COVID-19 and Psoriasis | Peter van de Kerkhof, MD, PhD | Netherlands
  
• Challenging Case: Linfoma Después del Tratamiento Biológico: ¿Qué fue primero? | Angela Londoño, MD | Colombia
  
• Challenging Case: Paradoxical Psoriasis Induced by Anti-TNF | Romina Contreras, MD | Paraguay
• Challenging Case: To Be or Not to Be? It is Not Always Psoriasis. | Fernando Valenzuela, MD | Chile
  
• Challenging Case: Eventos Adversos Cutáneos Durante La Terapia Biológica. | André Vicente Esteves de Carvalho, MD, PhD | Brazil
• Faculty Discussion | All faculty

Hot topics and challenging cases in psoriasis: A focus on COVID-19 and systemic/biologic treatment

2020 EADV Virtual

• An Elderly Patient with Severe Psoriasis - Which Treatment to Consider | Peter van de Kerkhof, MD, PhD | Netherlands
  
• Challenging case: How to Switch to the Most Optimal Treatment | Craig Leonardi, MD | USA
  
• Challenging case: Patient at Risk for Developing Severe Case COVID-19 | Lluis Puig, MD, PhD | Spain
• Choosing the MostAppropriate First Line Biologic | Richard Warren, BSc, MBChB, FRCP, PhD | UK
  
• How to Select a Systemic Treatment for Your Patient | Craig Leonardi, MD | USA

JSPR-IPC Joint Symposium: Personalized medicine in Psoriasis

2020 JSPR Virtual

• The Concept of Personalized Medicine in the Treatment of Psoriasis | Peter van de Kerkhof, MD, PhD | Netherlands

Search ALl videos